DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Pinter M, Sieghart W, Reiberger T, Rohr-Udilova N, Ferlitsch A, Peck-Radosavljevic M.
The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study.
Aliment Pharmacol Ther 2012;
35 (01) 83-91
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.